4/8/2019 | BKCVHY | S&P upgrades Horizon
|
3/18/2019 | HYLM | Horizon Pharma pays down term loans, plans to repay 6 5/8% notes
|
3/6/2019 | BKHY | S&P puts Horizon Pharma on positive watch
|
10/25/2016 | HY | Market Commentary: Sprint, T-Mobile see some movement; new Netflix, URI trade; communications ride AT&T takeover talks
|
10/19/2016 | HY | Market Commentary: NGL Energy, Horizon Pharma price; new NGL notes jump; Sprint on tap; coal names catch fire
|
10/19/2016 | HY | New Issue: Horizon Pharma prices $300 million eight-year notes at par to yield 8¾%
|
10/14/2016 | HY | Market Commentary: Primary quiet to close out $770 million week; UCP slates deal; Lions Gate, Warner continue rise
|
10/13/2016 | HY | Market Commentary: Warner Music, Lions Gate price, gain; Horizon shops deal; Rackspace rises; funds lose $72 million
|
10/13/2016 | CLHY | Market Commentary: Confie Seguros, Platform Specialty, Guggenheim Partners, ConvergeOne, Lions Gate break
|
10/13/2016 | HY | Market Commentary: Morning Commentary: Junk lower amid weaker equities; Warner Music euro tranche prices tight
|
10/13/2016 | HY | Horizon Pharma starts roadshow for $300 million eight-year notes; initial guidance 8½%
|
10/11/2016 | CLHY | Market Commentary: Rocket Software, Harbortouch, Intrawest Operations break; Confie Seguros reveals changes
|
4/12/2016 | HY | Market Commentary: Distressed energy debt rallies on output cut hopes; healthcare convertibles underperform
|
12/3/2015 | BKBWCVHYLW | Horizon Pharma has 4.6x leverage, could go to 6x for right opportunity
|
10/23/2015 | HY | Market Commentary: Valeant leads pharma rebound; Platform Specialty off as CEO plans exit; energy names slide
|
10/22/2015 | HY | Market Commentary: Valeant, other drug makers continue slide; hospital names trade off; energy credits lower
|
10/21/2015 | HY | Market Commentary: Valeant clobbered as report alleges fraud; other pharmaceuticals fall; oil credits lower
|
10/20/2015 | HY | Market Commentary: Valeant bonds shed Monday gains; Horizon Pharma converts slide; AMD firm despite downgrade
|
4/23/2015 | CLHY | Market Commentary: Charter term G dips with acquisition worries; DJO Finance, Horizon Pharma changes emerge
|
4/21/2015 | BKCVHY | S&P: Horizon Pharma loan BB-, notes B-, convertibles CCC+
|
4/20/2015 | CLHY | Market Commentary: TGI Friday’s breaks; Staples, Kloeckner revised; Horizon Pharma, Intrawest, Talbots set talk
|
4/13/2015 | BKHY | Horizon’s revised financing to include $800 million of loans, notes
|
3/30/2015 | BKHY | Horizon Pharma gets $900 million debt commitment for Hyperion purchase
|